Henoch Schonlein purpura (HSP): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Henoch Schonlein purpura (HSP): management. Normal or raised white cell counts, Eosinophilia is possible. Fully referenced neurology checklist.
Laboratory features
- Normal or raised white cell counts
- Eosinophilia is possible
Other investigations
Locked: subscribe to see this section.
Treatment
Locked: subscribe to see this section.
Outcome
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Kraft DM, Mckee D, Scott C. Henoch-Schönlein purpura: a review. Am Fam Physician 1998; 58:405-408.
- Bluman J, Goldman RD. Henoch-Schönlein purpura in children: limited benefit of corticosteroids. Can Fam Physician 2014; 60:1007-1010.
- Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. Eur J Pediatr 2019; 178:1275-1281.
- Hernández-Rodríguez J, Carbonell C, Mirón-Canelo JA, Diez-Ruiz S, Marcos M, Chamorro AJ. Rituximab treatment for IgA vasculitis: a systematic review. Autoimmun Rev 2020; 19:102490.
- Maritati F, Fenoglio R, Pillebout E, et al. Brief report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein). Arthritis Rheumatol 2018; 70:109-114.
- And 2 more. Subscribe to see the full list
